Erica Gunnells
Family · Charleston, SCNPI 1912131285
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 43 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,919, 2.4 times the $786 reported in 2021. Among family clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$1K
- Lilly USA, LLC$646
- Sanofi-aventis U.S. LLC$594
- AbbVie$527
- Xeris Pharmaceuticals, Inc.$489
- Medtronic$433
- plus $3K from 37 others
What the payments were for
- Food & beverage$7,112100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$7,112 in reported general payments places this provider in the 95th percentile of 3,248 family providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 489 | $653,722 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 116 | $189,891 |
| OzempicSemaglutide | 90 | $148,350 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 85 | $107,909 |
| JardianceEmpagliflozin | 95 | $92,715 |
| JanuviaSitagliptin Phosphate | 73 | $77,700 |
| TrulicityDulaglutide | 42 | $71,244 |
| Tresiba Flextouch U-200Insulin Degludec | 51 | $64,118 |
| RybelsusSemaglutide | 38 | $57,493 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $53,175 |
| FarxigaDapagliflozin Propanediol | 24 | $34,917 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 33 | $26,362 |
| KerendiaFinerenone | 20 | $23,248 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $17,212 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 21 | $16,863 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $646 | $743,038583 claims |
| Novo NordiskOzempic, Rybelsus, Novolog, Novolog Mix 70-30 | $194 | $215,501158 claims |
| Boehringer IngelheimJardiance, Trijardy Xr | $53 | $109,578116 claims |
| MerckJanuvia, Janumet Xr | $12 | $104,062106 claims |
| AstraZenecaFarxiga | $52 | $34,91724 claims |
| BayerKerendia | $1,029 | $23,24820 claims |
| AbbVieSynthroid | $527 | $11,807105 claims |
| Antares Pharma, Inc.Xyosted | $86 | $8,25113 claims |
| Amneal Pharmaceuticals LLCUnithroid | $293 | $53923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,248 family providers in South Carolina.
Other family in Charleston
- Gwen ShattuckCharleston$13K
- Amber WardCharleston$12K
- Sara ChristieGreenville$229K
- Kara Cooper GilmerAnderson$127K
- Jessica BellEasley$96K
- Carrie HendersonGreenville$91K
- Sarah ValerioGreer$76K
- Mary WilliamsColumbia$67K
- Michelle StrongGreenville$55K
- Karen McKerihanSummerville$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.